I don't think that a partnership will include any (or at best very little) equity for the company we will partner with. I don't think that any BP (Merck, LOL) care if they get equity in NWBO in a partnership deal. They just need exclusivity for DCVax-L for the cancer indications that their Checkpoint inhibitor is currently selling the most and maybe for some of the indications that their checkpoint inhibitor is not having success with. They need to extend the patent life for their checkpoint inhibitor by partnering with NWBO. I am not saying that they would not want equity, but I don't see LP and co to be willing to part with equity at the current or immediate future SP. JMHO